Bruce E. Brockstein, MD | NorthShore

Dr. Bruce E. Brockstein

Claim this profile

NorthShore University HealthSystem-Evanston Hospital

Studies Brain Tumor
Studies Glioblastoma
11 reported clinical trials
21 drugs studied

Area of expertise

1

Brain Tumor

Bruce E. Brockstein has run 2 trials for Brain Tumor. Some of their research focus areas include:

Stage IV
2

Glioblastoma

Bruce E. Brockstein has run 2 trials for Glioblastoma. Some of their research focus areas include:

TMB
EGFR
+7/-10

Affiliated Hospitals

Image of trial facility.

NorthShore University HealthSystem-Evanston Hospital

Image of trial facility.

NorthShore University HealthSystem-Glenbrook Hospital

Clinical Trials Bruce E. Brockstein is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

Image of trial facility.

Radiation Therapy vs Observation

for Meningioma

This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.

Recruiting

2 awards

Phase 3

12 criteria

More about Bruce E. Brockstein

Clinical Trial Related

2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Bruce E. Brockstein has experience with

  • Nivolumab
  • Ipilimumab
  • Radiation Therapy
  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Single Fraction Stereotactic Radiosurgery

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Bruce E. Brockstein specialize in?

Is Bruce E. Brockstein currently recruiting for clinical trials?

Are there any treatments that Bruce E. Brockstein has studied deeply?

What is the best way to schedule an appointment with Bruce E. Brockstein?

What is the office address of Bruce E. Brockstein?

Is there any support for travel costs?